Soluble urokinase plasminogen activator receptor in one-year prediction of major adverse cardiac events in patients after first myocardial infarction treated with primary percutaneous coronary intervention
Introduction Soluble urokinase plasminogen activator receptor (suPAR) level reflects the general condition of the organism and was proved to give independent information in risk stratification of patients. The aim of this study was to assess the usefulness of suPAR in the prediction of adverse cardi...
Enregistré dans:
Auteurs principaux: | Rafał N. Wlazeł, Marta Migała, Marzenna Zielińska, Lucjan Pawlicki, Kinga Rośniak-Bąk, Iwona Szadkowska |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Termedia Publishing House
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/7fcfa377e41c48a99e99c25d85b8ff4c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The interrelationship of bone and cardiovascular remodeling biomarkers and clinical peculiarities of coronary artery disease in postmenopausal women
par: Natalia Serhiivna Mykhailovska, et autres
Publié: (2020) -
Age and gender aspects of the association of generalized obesity with development of fatal and nonfatal cardiovascular events (results of the prospective cohort study “Interepepid”)
par: A. G. Polupanov, et autres
Publié: (2021) -
LASSO and Bioinformatics Analysis in the Identification of Key Genes for Prognostic Genes of Gynecologic Cancer
par: Shao-Hua Yu, et autres
Publié: (2021) -
Identification of TNFAIP8 as an Immune-Related Biomarker Associated With Tumorigenesis and Prognosis in Cutaneous Melanoma Patients
par: Yuliang Sun, et autres
Publié: (2021) -
Association of glycated hemoglobin A1c levels with cardiovascular outcomes in the general population: results from the BiomarCaRE (Biomarker for Cardiovascular Risk Assessment in Europe) consortium
par: Christoph Sinning, et autres
Publié: (2021)